Telling Science & Therapeutic Stories

Concert Pharmaceuticals’ innovation with deuterium chemistry led to progress with drug candidates in clinical development, including a proprietary investigational medicine for alopecia areata, an autoimmune disease that causes hair loss. As a disease with no approved treatment options, few research studies, and a lack of patient awareness, Concert wanted to create an educational resource for alopecia areata research. We developed an online campaign and educational microsite sponsored by Concert, which resulted in targeted awareness to audiences seeking information on this disease.